Théa to Acquire Branded Ophthalmic Products from Akorn, Expanding Théa’s Presence into the U.S. Eye Care Industry

CLERMONT-FERRAND, France--(BUSINESS WIRE)--Laboratoires Théa SAS (“Théa”), Europe’s leading independent pharmaceutical company specializing in the research, development, and commercialization of eye-care products, today announced an agreement to purchase seven branded ophthalmic products from Akorn Operating Company LLC. The transaction will make Théa a best-in-class provider of products designed to fill the needs of eye-care professionals across the United States. The purchase will add seven e